ArticleJournal of movement disorders2021

Emerging Nondopaminergic Medications for Parkinson's Disease: Focusing on A2A Receptor Antagonists and GLP1 Receptor Agonists.

Pei Shang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.